Indraprastha Medical Corporation Limited

NSE: INDRAMEDCO · Unclassified

₹330.20-1.06%06 Nov 2026

Ask the data

Instant answers about Indraprastha Medical Corporation Limited — computed from its filings, no language model

Market cap₹3,027 cr

Current price₹330.20

High / Low₹623 / ₹300

P/E15.8

P/B3.72

Book value₹88.8

ROE23.6%

ROCE32.5%

Debt / equity0.00

Dividend yield1.36%

EPS (TTM)₹20.96

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	748	788	831	613	888	1,099	1,245	1,356	1,483
EBITDA	72	81	86	40	114	151	193	244	267
Operating margin	9.6%	10.2%	10.4%	6.6%	12.9%	13.7%	15.5%	18.0%	18.0%
Interest	9	7	6	3	3	4	4	6	6
Depreciation	31	30	33	33	35	39	40	44	44
Profit before tax	34	45	48	4	79	117	166	216	246
Tax	13	16	5	2	20	31	42	55	62
Net profit	21	28	44	2	59	86	124	161	184
EPS ₹	2.30	3.10	4.76	0.25	6.39	9.40	13.52	17.56	20.03
Operating cash flow	—	—	—	—	71	144	200	157	167
Capex	—	—	—	—	29	45	69	36	60
Dividend paid	—	—	—	—	0	23	28	41	41
Total assets	—	—	—	—	—	555	723	852	991
Equity	—	—	—	—	—	379	478	597	740

Quarterly performance

last 35 quarters · ₹ crore

showing latest 8 of 35 periods

	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	189	189	200	198	200	204	216	210	200	94	141	180	198	203	233	237	216	263	284	278	274	307	317	306	315	348	350	325	334	365	381	372	365	406	413
Operating profit	20	20	21	20	19	23	23	24	18	-25	9	26	30	30	25	31	28	37	44	38	33	47	50	47	48	67	64	52	61	73	71	62	61	80	77
Operating margin	10.5%	10.3%	10.7%	10.3%	9.7%	11.1%	10.4%	11.2%	8.7%	-26.6%	6.7%	14.4%	15.1%	14.8%	10.9%	13.2%	12.8%	14.0%	15.3%	13.6%	12.1%	15.4%	15.9%	15.4%	15.4%	19.3%	18.2%	16.1%	18.4%	20.0%	18.7%	16.7%	16.6%	19.7%	18.8%
Other income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	1	1	2	5	4	4	4	5	5	6	5	6	7	7	7	7	8	9
Interest	2	2	2	2	2	2	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2	2	1	2	2	1	1	2	2
Depreciation	8	8	8	7	7	8	8	8	8	8	8	8	8	9	9	9	9	10	10	10	10	10	10	10	10	11	11	11	11	10	11	11	11	12	12
Profit before tax	10	10	12	11	11	13	13	14	8	-34	0	17	21	21	16	22	20	27	34	29	27	40	44	41	42	60	57	45	55	68	66	56	55	75	72
Tax	5	4	5	4	4	5	-5	3	2	-9	-0	5	6	5	4	6	5	7	9	9	7	10	11	11	10	15	15	12	14	17	17	15	13	19	18
Net profit	6	0	0	0	7	0	18	11	6	-25	0	12	15	15	12	16	15	20	25	21	20	30	33	29	31	45	42	33	41	51	49	41	42	56	54
EPS ₹	0.61	0.71	0.84	0.78	0.78	0.93	1.96	1.16	0.71	-2.75	0.05	1.31	1.65	1.68	1.32	1.74	1.66	2.21	2.74	2.28	2.16	3.33	3.58	3.21	3.40	4.88	4.63	3.58	4.47	5.61	5.40	4.47	4.55	6.09	5.84
Revenue YoY	—	—	—	—	6.0%	7.6%	8.0%	6.2%	0.0%	-53.7%	-34.7%	-14.5%	-1.2%	115.4%	65.1%	31.4%	8.9%	29.8%	22.1%	17.4%	27.0%	16.4%	11.5%	10.4%	14.8%	13.5%	10.4%	6.0%	6.0%	4.9%	8.9%	14.4%	9.3%	11.3%	8.4%
Profit YoY	—	—	—	—	27.8%	—	—	—	-8.8%	—	-97.5%	12.2%	132.3%	—	2643.2%	32.9%	0.7%	31.3%	108.2%	31.3%	30.5%	50.4%	30.7%	40.9%	57.1%	46.8%	29.1%	11.4%	31.6%	14.9%	16.7%	25.0%	1.7%	8.5%	8.3%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Indraprastha Medical Corporation Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	402	437	458	523	607	678	713	758	767
Operating profit	58	70	66	68	79	91	85	76	79
Operating margin	14.4%	16.0%	14.4%	13.0%	12.9%	13.4%	11.9%	10.1%	10.3%
Other income	—	—	—	—	1	1	1	2	2
Interest	6	4	4	6	9	10	8	7	8
Depreciation	19	19	21	22	26	28	28	27	31
Profit before tax	37	47	45	40	45	54	50	44	42
Tax	13	15	15	13	17	19	17	16	15
Net profit	24	31	31	27	29	35	32	28	27

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	86	81	80	92	101	103	106	108	117	108	104	110	114	113	121	126	129	130	138	148	152	150	157	166	177	168	167	178	183	176	176	188	195	189	186	194	194	191	187	184	191	184
Operating profit	7	4	4	10	15	18	15	18	20	17	15	18	18	15	15	17	17	15	19	19	20	20	20	24	26	22	19	22	24	19	20	22	24	16	15	22	22	18	17	17	18	18
Operating margin	7.9%	4.3%	5.0%	11.4%	15.0%	17.2%	13.9%	16.7%	16.8%	16.1%	14.1%	16.1%	15.5%	13.5%	12.6%	13.4%	13.3%	11.5%	13.6%	12.9%	12.9%	13.0%	13.0%	14.3%	14.5%	13.2%	11.5%	12.2%	13.0%	11.0%	11.4%	11.5%	12.1%	8.3%	8.3%	11.2%	11.4%	9.5%	8.9%	9.2%	9.5%	9.8%
Other income	6	8	8	4	—	—	—	—	—	—	—	—	—	—	4	—	—	—	—	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	2	0	0	0	1	0	0	1
Interest	1	2	2	2	2	1	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2	3	2	2	2	3	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2
Depreciation	4	4	4	4	5	5	5	5	5	5	4	5	5	5	5	5	5	6	6	6	6	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	8	8	8	8	8
Profit before tax	7	6	6	8	9	12	9	12	14	11	10	12	11	9	14	10	10	8	11	12	12	10	12	14	16	12	11	12	15	10	12	13	15	7	9	13	13	9	7	7	8	8
Tax	3	2	2	3	3	4	3	4	5	4	3	4	4	3	4	3	3	3	4	4	4	3	5	5	5	5	4	4	5	3	4	5	5	2	3	4	5	3	3	3	3	3
Net profit	5	4	4	5	6	7	5	8	9	7	7	8	8	6	9	7	7	5	8	8	8	6	6	10	11	8	7	8	10	7	8	8	10	5	6	8	8	6	5	5	5	6
EPS ₹	0.51	0.43	0.39	0.54	0.65	0.82	0.60	0.87	0.94	0.79	0.79	0.85	0.83	0.64	1.03	0.76	0.77	0.60	0.82	0.88	0.84	0.71	0.71	1.05	1.18	0.85	0.78	0.91	1.07	0.74	0.83	0.87	1.09	0.51	0.60	0.91	0.89	0.63	0.51	0.52	0.57	0.60
Revenue YoY	—	—	—	—	18.4%	27.2%	33.4%	17.8%	15.5%	4.7%	-2.4%	1.0%	-2.3%	5.1%	16.9%	15.3%	13.1%	14.5%	13.5%	17.5%	17.3%	15.8%	13.9%	11.6%	16.9%	11.8%	6.6%	7.7%	3.5%	4.7%	5.4%	5.2%	6.2%	7.5%	5.9%	3.4%	-0.2%	1.3%	0.5%	-5.0%	-1.7%	-3.8%
Profit YoY	—	—	—	—	26.7%	90.1%	54.2%	59.9%	45.3%	-3.3%	31.7%	-1.9%	-12.4%	-18.3%	30.4%	-10.7%	-7.1%	-7.1%	-20.4%	15.9%	9.8%	18.2%	-13.7%	18.4%	41.2%	20.1%	10.6%	-12.8%	-9.8%	-13.2%	5.6%	-4.3%	1.6%	-30.2%	-26.8%	4.8%	-18.4%	21.9%	-15.5%	-43.2%	-35.6%	-3.8%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 32 periods

	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	22.3%	23.7%	22.7%	25.4%	25.1%	27.2%	25.9%	28.9%	28.2%	28.8%	27.0%	28.1%	26.5%	27.8%	24.8%	25.4%	23.6%
ROCE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	31.1%	33.2%	32.0%	35.4%	34.7%	37.4%	35.6%	39.8%	39.0%	39.8%	37.3%	38.8%	36.5%	38.3%	34.0%	34.9%	32.5%
Net margin	0.7%	0.9%	0.9%	3.1%	4.3%	4.2%	1.4%	-1.2%	-1.0%	0.4%	5.9%	6.7%	6.7%	6.6%	6.7%	7.7%	7.8%	7.8%	8.4%	8.9%	9.4%	10.0%	10.7%	11.2%	11.3%	11.9%	12.2%	12.4%	12.6%	12.4%	12.3%	12.4%
EBITDA margin	10.4%	10.2%	10.5%	10.4%	10.6%	10.4%	5.4%	3.9%	4.5%	6.6%	13.2%	13.7%	13.4%	12.9%	12.8%	13.9%	14.0%	13.8%	14.2%	14.3%	14.8%	15.5%	16.6%	17.2%	17.3%	18.0%	18.2%	18.4%	18.4%	18.0%	18.0%	18.0%
Debt / equity	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	6.92	7.50	8.01	8.33	9.21	9.14	1.23	-1.65	-1.28	2.28	17.45	21.76	23.14	24.19	24.62	25.89	27.62	28.38	34.40	42.69	46.03	41.91	38.93	36.30	32.96	35.50	37.18	39.18	41.91	41.87	42.33	42.26
Asset turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1.72	1.79	1.98	2.06	1.76	1.80	1.72	1.78	1.64	1.66	1.59	1.61	1.47	1.52	1.50	1.54	1.39

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	92	92	92	92	92	92	92	92	92
Other equity / reserves	252	288	323	386	433	505	567	649	723
Total equity	344	379	415	478	524	597	658	740	814
Borrowings	0	0	0	0	0	0	0	0	0
Current liabilities	198	130	207	165	203	179	223	170	223
Non-current liabilities	39	46	46	80	79	76	73	81	81
Total assets	580	555	668	723	806	852	954	991	1,118
Property, plant & equipment	274	274	280	346	341	327	350	364	387
Capital work-in-progress	0	3	31	0	0	33	2	3	3
Investments	0	0	51	0	0	0	39	0	353
Inventories	10	8	8	8	8	7	8	8	8
Receivables	60	68	68	58	75	75	99	112	132
Cash & equivalents	78	52	38	62	67	61	3	5	6

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	71	144	200	157	167
Cash from investing	-51	-108	-158	-111	-178
Cash from financing	-3	-26	-32	-46	-46
Capex	29	45	69	36	60
Free cash flow	42	100	131	120	108
Dividends paid	0	23	28	41	41

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹387 cr35%

CWIP

₹3 cr0%

Investments

₹353 cr32%

Inventories

₹8 cr1%

Receivables

₹132 cr12%

Cash & equivalents

₹6 cr1%

Other assets

₹230 cr21%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Indraprastha Medical Corporation Limited	3,027	330.20	15.8	3.72	23.6%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+0.2%

6 months-20.7%

1 year-42.1%

3Y CAGR+22.8%

5Y CAGR+34.5%

10Y CAGR+19.2%

50-day avg₹340.66

200-day avg₹377.28

RSI (14)56

FAQs

What is the share price of Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited (INDRAMEDCO) closed at ₹330.20 on NSE on 06 Nov 2026.

What is the market cap of Indraprastha Medical Corporation Limited?

₹3,027 crore at the latest close.

What is the P/E ratio of Indraprastha Medical Corporation Limited?

15.8, on trailing-twelve-month earnings from its filings.

How fast is Indraprastha Medical Corporation Limited growing?

Indraprastha Medical Corporation Limited: revenue has compounded at 10.5% a year over three years; net profit at 28.7% a year. Latest-quarter revenue is up 8.4% year on year, profit up 8.3%.

How profitable is Indraprastha Medical Corporation Limited?

On a trailing-twelve-month basis return on equity is 23.6%, return on capital employed 32.5%, operating margin 18.0%, net margin 12.4%.

How much debt does Indraprastha Medical Corporation Limited have?

Indraprastha Medical Corporation Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹6 cr (balance sheet of 2026-09-30). Operating profit covers interest 42.3 times.

Financials parsed from Indraprastha Medical Corporation Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.